-
Innovation Ranking
Innovation Ranking - Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company that manufactures and supplies generic pharmaceutical products. The company's product portfolio includes oral solids, oncology OSD, general and oncology injectables, generic formulations, and ophthalmic and dermatology products. It offers products for various therapy areas such as cardiovascular, analgesics, genecology, cough and cold, gastroenterology, ophthalmology, anti-diabetics, orthopedic, urology and dermatological therapies. API company operates manufacturing facilities in Gujarat and Sikkim, India and research centers in Vadodara and Hyderabad, India and New Jersey, the...
-
Innovation Ranking
Innovation Ranking - Palatin Technologies Inc
Palatin Technologies Inc (Palatin) is a biopharmaceutical company that develops receptor specific peptide therapeutics. The company’s medicines are based on molecules that control the activity of the melanocortin and natriuretic peptide receptor systems. Its lead product includes Vyleesi, indicated for the treatment of premenopausal women with hypoactive sexual desire disorder. Palatin clinical pipeline includes melanocortin receptor programs such as PL-8177 MC1r Agonist (oral) for inflammatory bowel disease; PL9643 MCr Agonist for dry eye diseases; PL-8177 MC1r Agonist (systemic) for Covid-19...
-
Innovation Ranking
Innovation Ranking - Medytox Inc
Medytox Inc (Medytox) is a pharmaceutical company that develops, manufactures and markets biopharmaceutical products. The company offering products includes botulinum toxin, hyaluronic acid filler and medical device. its botulinum toxin type a product comprises neuronox, innotox and coretox. Medytox hyaluronic acid filler provides neuramis an potenfill. The company also offer neurakin cream. The company provide comfortdual, a medical device for tissue coagulation by using high-frequency current. It has operations with manufacturing plants, research and development centers and joint venture companies...
-
Innovation Ranking
Innovation Ranking - Sapporo Holdings Ltd
Sapporo Holdings Ltd (SHL) is a manufacturer and provider of alcoholic beverages and food products and services. The company’s product portfolio include alcoholic and non-alcoholic beverages, comprises of beer, wine, carbonated drinks, tea drinks, coffee drinks, lemon-based products and soups. It also offers leasing services and operational services. SHL operates restaurants under Ginza Lion, Dubliners, Tomoru, Kokuimo, Sapporo and Yebisu banners. It caters its services to various restaurants, and hotels. The company owns, manages, operates and develops real estate business....
-
Innovation Ranking
Innovation Ranking - Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic tension-type headache. Its products include oral formulation, smallpox vaccine, disintegrating sublingual tablets and tonmya. Tonix’s tonmya is a lead product candidate, designed as a bedtime treatment for post traumatic stress disorder. Its disintegrating sublingual tablets contain a dose and formulation of cyclobenzaprine...
-
Innovation Ranking
Innovation Ranking - Ocugen Inc
Ocugen Inc (Ocugen) Is a biopharmaceutical company that discovers, develops and commercializes drugs for treatment. It is investigating OCU-400 against NR2E3, RHO, CEP290, and PDE6B mutation-associated retinal degeneration; and OCU-410 targeting dry age-related macular degeneration. The company is developing OCU200 drugs to treat diabetic macular edema, diabetic retinopathy, and wet-age-related macular degeneration. Ocugen is also investing OCU410ST for stargardt orphan disease. It utilizes a modified gene therapy platform to develop its products. The company operates in Ireland and the US....
-
Innovation Ranking
Innovation Ranking - Biocon Ltd
Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions such as cancer, diabetes and autoimmune diseases. It offers a range of active pharmaceutical ingredients (APIs), branded formulations, complex biologics and biosimilars including monoclonal antibodies (MAbs), rh-Insulin and insulin analogs. The company also provides services including contract manufacturing, drug licensing, research, development and manufacturing of small and large molecules for biotechnology and pharmaceutical companies across the world. It...
-
Innovation Ranking
Innovation Ranking - Epizyme Inc
Epizyme Inc (Epizyme) is a biopharmaceutical company that discovers, develops, and markets novel epigenetic therapies for the treatment of cancer and other diseases. The company’s marketed products include Tazverik (tazemetostat), an oral, first-in-class, small-molecule inhibitor of EZH2 for the treatment of patients with metastatic or locally advanced epithelioid sarcoma and relapsed/refractory follicular lymphoma. Its pipeline products include tazemetostat for follicular lymphoma, DLBCL, epithelioid sarcoma and prostate cancer; PRMT 1 Inhibitor (GSK3368715) for solid tumors and DLBCL; and PRMT5 (GSK3368715) for...
-
Innovation Ranking
Innovation Ranking - Alkem Laboratories Ltd
Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The company’s product portfolio includes active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for acute and chronic diseases such as central nervous system disorders, gastro-intestinal infections, metabolic disorders and diabetes, cancer, skin and hair diseases, urologic diseases, cardiovascular diseases, immune disorders and pain relief. It also offers vitamins, minerals and nutrition products. The company distributes its products directly...
-
Innovation Ranking
Innovation Ranking - Blueprint Medicines Corp
Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is precision therapy company that inventing medicines for people with cancer and blood disorders. The company product pipeline includes AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST) and GAVRETO (pralsetinib) against non-small cell lung cancer in adults, BLU-263 targeting indolent systemic mastocytosis. It also offer GAVRETO, BLU-701, BLU-945, BLU-451, BLU-222 and BLU-852. Blueprint Medicines is advancing pralsetinib inhibitor against RET (Ret Proto-Oncogene) modified medullary thyroid carcinoma and other solid tumors...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.